Frank Torti - 12 Apr 2023 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Director
Signature: /s/ Eva Renee Barnett, attorney-in-fact for Frank Torti
Issuer symbol: IMVT
Transactions as of: 12 Apr 2023
Net transactions value: $0
Form type: 4
Filing time: 14 Apr 2023, 16:29:07 UTC
Previous filing: 29 Sep 2022
Next filing: 26 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Award	$0	+121,916	+31%	$0.000000	515,274	12 Apr 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMVT	Stock Option (right to buy)	Award	$0	+158,292		$0.000000	158,292	12 Apr 2023	Common Stock	158,292	$14.70	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares underlying restricted stock units awards ("RSUs").
F2	The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
F3	Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.